Prenatal exposure to valproate and risk of congenital malformations-Could we have known earlier?-A population-based cohort study.
Jakob ChristensenBetina B TrabjergYuelian SunNils Erik GilhusMarte Helene BjørkTorbjörn TomsonJulie Werenberg DreierPublished in: Epilepsia (2021)
Using Danish health care data, we were able to identify a teratogenic risk associated with prenatal valproate exposure in children born in 1997, which is much earlier than prospective clinical cohorts. Health registry data represent an important tool for early identification of risk associated with drugs in pregnancy.